Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta] (2016)
- Autor:
- Autor USP: EVORA, PAULO ROBERTO BARBOSA - FMRP
- Unidade: FMRP
- DOI: 10.14503/THIJ-15-5629
- Subjects: ÓXIDO NÍTRICO; FÁRMACOS (SISTEMA CARDIOVASCULAR); DOENÇAS VASCULARES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Texas Heart Institute Journal
- ISSN: 0730-2347
- Volume/Número/Paginação/Ano: v. 43, n. 1, p. 103, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
EVORA, Paulo Roberto Barbosa. Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta]. Texas Heart Institute Journal. Houston: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.14503/THIJ-15-5629. Acesso em: 24 abr. 2024. , 2016 -
APA
Evora, P. R. B. (2016). Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta]. Texas Heart Institute Journal. Houston: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.14503/THIJ-15-5629 -
NLM
Evora PRB. Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta] [Internet]. Texas Heart Institute Journal. 2016 ; 43( 1): 103.[citado 2024 abr. 24 ] Available from: https://doi.org/10.14503/THIJ-15-5629 -
Vancouver
Evora PRB. Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta] [Internet]. Texas Heart Institute Journal. 2016 ; 43( 1): 103.[citado 2024 abr. 24 ] Available from: https://doi.org/10.14503/THIJ-15-5629 - Budd-chiari syndrome in a 25-year-old woman with behçet's disease: a case report and review of the literature
- Endothelium dysfunction classification [Carta]: keeping the discussion opened
- Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta]
- Effect of the chronic metabollic acidosis on rat thoracic aorta reactivity
- Evolution of the Brazilian Journal of Cardiovascular Surgery [Editorial]
- Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…"
- Presentation of an experimental method to induce in vitro ("organ chambers") respiratory acidosis and its effects on vascular reactivity
- Vasopressor support sparing strategies [Editorial]: a concept to be incorporated as a paradigm in the treatment of vasodilatory shock
- Possible advances in vasopressors and inotropes support in shock. [Carta]
- Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue
Informações sobre o DOI: 10.14503/THIJ-15-5629 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
